EFFECT OF GENOTYPE (ACTN3) ON THE LEVEL OF ACHIEVEMENT AS A DETERMINANT FOR SELECTING PHYSICAL STRENGTH PLAYERS
DOI:
https://doi.org/10.46827/ejfnsm.v5i1.184Keywords:
genotype (ACTN3), level achievementAbstract
The process of selecting sports talents is still based on basic determinants and the best practitioners of the event at the levels of various sports, which will rely on the training curricula later hoping to achieve in the championships and win medals, without focusing and taking into account the type of gene and genetic traits supporting this, so this process is random and incomplete lacks the elements of the foundations of success that are built on it, with the numbers of doses of training loads that will have the greatest impact and bear fruit to achieve the goals of the Olympic champion industry, and for this the determination of The pattern of gene expression that distinguishes emerging physical strength, which accelerates the ways to reach the required higher levels, and here the results of training emerge by saving a lot of effort, time and money, and this is what prompted the researchers to study the phenomenon of research and ask the question, what is the impact of gene patterns (ACTN3) on the level of achievement as a determinant for the selection of sports talents for physical strength players. The research aimed to find the effect of the patterns of the gene (ACTN3) and its association with the level of achievement of physical strength players. The researchers used the descriptive approach with correlation and identified the research community as players of the Iraq team for physical strength sports, junior group under the age of (15 years). The study came out with the following conclusions: (ACTN3) gene types, specifically the allele (RR), affect the strength and speed of muscle fiber contraction, unlike the endurance allele (XX).
References
Agata Leońska-Duniec: Genetic Research in Modern Sport, Central European Journal of Sport Sciences and Medicine, 3(3), 2013, 19–26.
Agnieszka Maciejewska-Skrendo, Marek Sawczuk, Pawel Cięszczyk, Ildus I. Ahmetov, Genes and power athlete status, Sports, Exercise, and Nutritional Genomics, 2019, 47.
Ahmetov I. I., Fedotovskaya O.N. Sports genomics: Current state of knowledge and future directions. Cell. Mol. Exerc. Physiol. 1(1), 2012, 1–25.
Alfred T, Ben-Shlomo Y, Cooper R, Hardy R, Cooper C, et al, Day IN. ACTN3 genotype, athletic status, and life course physical capability: meta-analysis of the published literature and findings from nine studies. Hum Mutat 32, 2011, 1008–1018.
Barbara Norman, Mona Esbjörnsson, Håkan Rundqvist, Ted Österlund, Birgitta Glenmark, and Eva Jansson, ACTN3 genotype and modulation of skeletal muscle response to exercise in human subjects, J Appl Physiol 116, 2014, 1197–1203.
Broos S, Malisoux L, Theisen D, Francaux M, Deldicque L, Thomis MA. Role of alpha-actinin-3 in contractile properties of human single muscle fibers: a case series study in paraplegics. PloS One 7, 2012, e49281.
Broos, S. Van Leemputte, M. Deldicque, L. Thomis, M.A. History-dependent force, angular velocity and muscular endurance in ACTN3 genotypes. Eur. J. Appl. Physiol, 115, 2015, 1637–1643.
David Varillas Delgado, Juan del Coso, Jorge Gutiérrez Hellín, et al. Genetics and sports performance, the present and future in the identification of talent for sports based on DNA testing, European Journal of Applied Physiology, 122, 2022, 1811–1830
Del Coso, J. Moreno, V. Gutiérrez-Hellín, J. Baltazar-Martins, G. Ruíz-Moreno, C. et al. ACTN3 R577X genotype and exercise phenotypes in recreational marathon runners. Genes, 10, 2019, 413.
Del Coso, J., Hiam, D., Houweling, P.J., Pérez, L.M., Eynon, N., Lucía, A. More than a 'speed gene': ACTN3 R577X genotype, trainability, muscle damage, and the risk for injuries. Eur. J. Apple. Physiol, 119, 2019, 49–60.
Eduardo M. Pimenta, Daniel B. Coelho, Christiano E. Veneroso, Ering J. Barros Coelho, et al., Effect of ACTN3 Gene On Strength and Endurance in Soccer Players, Journal of Strength and Conditioning Research, 27(12), 2013, 3286–3292.
Eynon N, Duarte JA, Oliveira J, Sagiv M, Yamin C, Meckel Y, Goldhammer E. ACTN3 R577X polymorphism and Israeli top-level athletes. Int J Sport Med 30, 2009, 695–698.
Eynon, N. Duarte, J.A. Oliveira, J. Sagiv, M. Yamin, C. Meckel, Y. Sagiv, M. Goldhammer, E. ACTN3 R577X polymorphism and Israeli top-level athletes. Int. J. Sports Med. 30, 2009, 695–698.
Foster, C. ACTN3 genotype in professional endurance cyclists. Int J Sports Med 27, 2006, 880–884.MacArthur, DG, Seto, J, Chan, S, Quinlan, KG, Raftery, JM, Turner, N, Nicholson, MD, Kee, AJ, Hardeman, EC, et al. An ACTN3 knockout mouse provides mechanistic insights into the association between alpha-actinin-3 deficiency and human athletic performance. Hum Mol Genet 17, 2008, 1076–1086.
Gentil, P. Pereira, R.W. Leite, T.K.M. Bottaro, M. ACTN3 R577X polymorphism and neuromuscular response to resistance training. J. Sport. Sci. Med, 10, 2011, 393–399.
Hampton CM, Taylor DW, Taylor KA. Novel structures for alphaactinin: F-actin interactions and their implications for actin-membrane attachment and tension sensing in the cytoskeleton. J Mol Biol 368, 2007, 92–104.
Hogarth, M.W. Garton, F.C. Houweling, P.J. Tukiainen, T. Lek, M. Macarthur, D.G. et al. Analysis of the ACTN3 heterozygous genotype suggests that α-actinin-3 controls sarcomeric composition and muscle function in a dose-dependent fashion. Hum. Mol. Genet, 25, 2016, 866–877.
Hornberger TA. Mechanotransduction and the regulation of mTORC1 signaling in skeletal muscle. Int j biochem cell biol 43, 2011, 1267–1276.
Houweling, P.J., Papadimitriou, I.D., Seto, J.T., Pérez, L.M., Coso, J.D., North, K.N., Lucia, A., Eynon, N. Is evolutionary loss our gain? The role of ACTN3 p. Arg577Ter (R577X) genotype in athletic performance, ageing, and disease. Hum. Mutat, 39, 2018, 1774–1787.
Jan Weyerstraß, Kelly Stewart, Anke Wesselius, Maurice Zeegers. Nine genetic polymorphisms associated with power athlete status—A Meta-Analysis. Journal of Science and Medicine in Sport, 21, 2018, 213–220.
Jones, N. Kiely, J. Suraci, B. Collins, D.J. Lorenzo, D.D. Pickering, C. Grimaldi, K.A. A genetic-based algorithm for personalized resistance training. Biol. Sport, 33, 2016, 117–126.
Lucia A, Gómez-Gallego F, Santiago C et al, ACTN3 genotype in professional endurance cyclists. Int J Sport Med 27, 2006, 880–884.
Lucia, A, Go ́mez-Gallego, F, Santiago, C, Bandre ́s, F, Earnest, C, Rabada ́n, M, Alonso, JM, et al. The association of sport performance with ACE and ACTN3 genetic polymorphisms: a systematic review and meta-analysis. PloS One 8, 2013, e54685.
MacArthur DG et al, An Actn3 knockout mouse provides mecha-nistic insights into the association between alpha-actinin-3 deWciency and human athletic performance. Hum Mol Genet 17, 2008, 1076–1086.
MacArthur DG, Seto JT, Chan S, Quinlan KG, Raftery JM, Turner N, Nicholson MD, et al. An Actn3 knockout mouse provides mechanistic insights into the association between alpha-actinin-3 deficiency and human athletic performance. Hum Mol Genet 17, 2008, 1076 –1086,
Myosotis Massidda, Giuseppe Vona, and Carla M. Calo, Association between the ACTN3 R577X Polymorphism and Artistic Gymnastic Performance in Italy, Genetic Testing and Molecular Biomarkers, 3(3), 2009, 377-380.
Naureen Z, Perrone M, Paolacci S, Maltese PE, Dhuli K, Kurti D, Dautaj A, Miotto R, Casadei A, Fioretti B, Beccari T, Romeo F, Bertelli M Genetic test for the personalization of sport training. Acta Biomed 91(13-s), 2020, e2020012.
Niemi AK, Majamaa K. Mitochondrial DNA and ACTN3 genotypes in Finnish elite endurance and sprint athletes. Eur J Hum Genet 13, 2005, 965–969.
Norman, B. Esbjörnsson, M. Rundqvist, H. Österlund, T. Glenmark, B. Jansson, E. ACTN3 genotype and modulation of skeletal muscle response to exercise in human subjects. J. Appl. Physiol, 116, 2014, 1197–1203.
Paparini A, Ripani AM, Giordano GD, et al. ACTN3 genotyping by real-time PCR in the Italian population and athletes. Med Sci Sports Exerc 39, 20007, 810–815.
Seto JT, Lek M, Quinlan KG, Houweling PJ, Zheng XF, Garton F, MacArthur DG, Raftery JM, Garvey SM, Hauser MA, Yang N, Head SI, North KN. Deficiency of alpha-actinin-3 is associated with increased susceptibility to contraction-induced damage and skeletal muscle remodeling. Hum Mol Genet 20, 2011. 2914 –2927.
Tanisawa K, Wang G, Seto J, Verdouka I, Twycross-Lewis R, Karanikolou A, Tanaka M, et al, Sport and exercise genomics: the FIMS 2019 consensus statement update. Br J Sport Med 54(16), 2020, 969–975.
Vincent B, Windelinckx A, Nielens H et al, Protective role of al-pha-actinin-3 in the response to an acute eccentric exercise bout. J Appl Physiol, 109(2), 2010, 564–573.
Walsh, S. Liu, D. Metter, E.J. Ferrucci, L. Roth, S.M. ACTN3 genotype is associated with muscle phenotypes in women across the adult age span. J. Appl. Physiol, 105, 2008, 1486–1491.
Yang N, MacArthur DG, Gulbin JP, Hahn AG, Beggs AH, Easteal S, North K. ACTN3 genotype is associated with human elite athletic performance. Um J Hum Genet 73, 2003, 627–631.
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
